Pages that link to "Q37830433"
Jump to navigation
Jump to search
The following pages link to Paola Bonsi (Q37830433):
Displaying 50 items.
- Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia (Q27321884) (← links)
- Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons (Q28260528) (← links)
- Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro (Q28302806) (← links)
- Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia (Q28648007) (← links)
- Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin. (Q30492449) (← links)
- Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. (Q30547556) (← links)
- Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons. (Q31883033) (← links)
- NR2B subunit exerts a critical role in postischemic synaptic plasticity (Q33245460) (← links)
- Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. (Q34094168) (← links)
- Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. (Q34187994) (← links)
- Role of tonically-active neurons in the control of striatal function: cellular mechanisms and behavioral correlates (Q34192393) (← links)
- Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors (Q35157626) (← links)
- Calcium signaling and neuronal vulnerability to ischemia in the striatum. (Q35839935) (← links)
- Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. (Q36145938) (← links)
- Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease. (Q36484666) (← links)
- Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies. (Q37211755) (← links)
- Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum. (Q37361261) (← links)
- Electrophysiology of 5-HT6 receptors. (Q37809905) (← links)
- Aberrant striatal synaptic plasticity in monogenic parkinsonisms. (Q37917012) (← links)
- Experimental models of dystonia (Q37930047) (← links)
- PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity (Q39647087) (← links)
- Coordinate high-frequency pattern of stimulation and calcium levels control the induction of LTP in striatal cholinergic interneurons (Q40608289) (← links)
- Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia (Q41785434) (← links)
- Centrality of striatal cholinergic transmission in Basal Ganglia function. (Q41915908) (← links)
- Powerful inhibitory action of mu opioid receptors (MOR) on cholinergic interneuron excitability in the dorsal striatum. (Q42442110) (← links)
- Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons. (Q42474830) (← links)
- Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of DYT1 Dystonia. (Q42504663) (← links)
- Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. (Q42590497) (← links)
- Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors (Q42971243) (← links)
- Optogenetic stimulation reveals distinct modulatory properties of thalamostriatal vs corticostriatal glutamatergic inputs to fast-spiking interneurons (Q43172110) (← links)
- Selective involvement of mGlu1 receptors in corticostriatal LTD. (Q43621325) (← links)
- An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease (Q43696876) (← links)
- Presynaptic modulation by group III metabotropic glutamate receptors (mGluRs) of the excitatory postsynaptic potential mediated by mGluR1 in rat cerebellar Purkinje cells (Q43721015) (← links)
- Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation (Q43940980) (← links)
- Impairment of mitochondrial metabolism differentially affects striatal neuronal subtypes (Q43970079) (← links)
- Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons (Q44282781) (← links)
- Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia (Q44351170) (← links)
- Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons. (Q44707390) (← links)
- Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons (Q45299250) (← links)
- The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum (Q47766445) (← links)
- Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition (Q47793274) (← links)
- Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice (Q48062897) (← links)
- Aflatoxin B1 is an inhibitor of cyclic nucleotide phosphodiesterase activity. (Q48177418) (← links)
- Functional and ultrastructural analysis of group I mGluR in striatal fast-spiking interneurons. (Q48209421) (← links)
- Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. (Q48319536) (← links)
- Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia. (Q48356145) (← links)
- Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. (Q48436385) (← links)
- Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia (Q48704737) (← links)
- Toxicity of selected plant volatiles in microbial and mammalian short-term assays (Q50124309) (← links)
- Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum (Q50420863) (← links)